%0 Journal Article
%T Complementary and Alternative Therapies for Pediatric Attention Deficit Hyperactivity Disorder: A Descriptive Review
%A H. Russell Searight
%A Kayla Robertson
%A Todd Smith
%A Scott Perkins
%A Barbara K. Searight
%J ISRN Psychiatry
%D 2012
%R 10.5402/2012/804127
%X Attention deficit hyperactivity disorder (AD/HD), characterized by impulsivity, distractibility, and inattention, has an estimated pediatric population prevalence of 6¨C8%. Family physicians and pediatricians evaluate and treat the majority of children with this condition. The evidence-based treatment of choice for ADHD, stimulant medication, continues to be a source of public controversy. Surveys suggest that among parents of children with ADHD, there is considerable interest in complementary and alternative medicine (CAM). These therapies include herbal preparations, mineral supplements, sugar restriction, and polyunsaturated fatty acids. Other AD/HD therapies include neuro-feedback, cognitive training, mindfulness meditation, and exposure to ¡°green space.¡± In order to assist physicians and mental health professionals in responding to patient and parent queries, this paper briefly describes these CAM therapies and current research regarding their effectiveness. While investigations in this area are hampered by research design issues such as sample size and the absence of double-blind placebo-controlled trials, there is some evidence that omega three fatty acids, zinc supplements, and neuro-feedback may have some efficacy. 1. Introduction Attention deficit hyperactivity disorder (AD/HD) is a psychiatric condition affecting an estimated 5¨C7% of children [1]. AD/HD¡¯s core symptoms of elevated impulsivity, increased motor activity, impaired concentration, and short-term memory deficits are often chronic with their symptomatic expression changing with development [2]. While stimulant pharmacotherapy is the evidence-based treatment of choice for AD/HD [3], complementary and alternative (CAM) therapies are becoming increasingly common treatments for the condition. In addition to chronicity, AD/HD has several other characteristics that make it a focus for CAM. While AD/HD is generally believed to stem from neurophysiological deficits [3], a precise etiology has yet to be established. The treatment of choice for the condition is a Schedule II stimulant medication with addiction potential. Stimulant medication, while efficacious, may be associated with side effects including facial tics, hypertension, and anorexia [3]. Finally, an estimated 20¨C30% of children with AD/HD do not respond to stimulant medication [4]. Surveys suggest that up to 60% of US patients use complementary and alternative medicine¡ªwith half of this group using CAM in the past year [5]. Children with chronic conditions are far more likely than the general pediatric population to use CAM [6].
%U http://www.hindawi.com/journals/isrn.psychiatry/2012/804127/